本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

91.17
+0.22000.24%
盤後91.170.00000.00%19:30 EDT
成交量:125.76萬
成交額:1.15億
市值:80.39億
市盈率:-45.36
高:93.07
開:91.38
低:90.48
收:90.95
52周最高:110.18
52周最低:14.51
股本:8,817.38萬
流通股本:8,097.70萬
量比:1.32
換手率:1.55%
股息:- -
股息率:- -
每股收益(TTM):-2.0100
每股收益(LYR):-1.9755
淨資產收益率:-22.98%
總資產收益率:-19.81%
市淨率:8.42
市盈率(LYR):-46.15

資料載入中...

2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC問詢函

Form CORRESP - Correspondence
2024/04/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/29

SEC問詢函

Form CORRESP - Correspondence
2024/03/27

SEC問詢函

Form CORRESP - Correspondence
2024/03/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

SEC問詢函

Form CORRESP - Correspondence
2024/03/14

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/02

SEC問詢函

Form CORRESP - Correspondence
2024/03/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]